undamentalytics Newsletter

Alkami Technology, Inc. key statistics and ratios

In fiscal 2025, Alkami Technology, Inc. had return on equity of -13.3%, an operating margin of -12.1%, debt equal to 92.9% of equity and a current ratio of 2.09. Each ratio below is calculated from the figures on its income statement, balance sheet and cash flow pages.

Financial ratios

US$ thousands unless shown otherwise. Fiscal years, plus the last twelve months (LTM) when newer.

Alkami Technology, Inc.: financial ratios, annual
Fiscal year2019Dec 20192020Dec 20202021Dec 20212022Dec 20222023Dec 20232024Dec 20242025Dec 2025
Gross margin41.4%52.8%55.1%53.0%54.4%58.9%57.8%
Operating margin−57.8%−31.3%−28.2%−28.2%−24.1%−13.4%−12.1%
Net margin−56.9%−45.8%−30.8%−28.7%−23.8%−12.2%−10.7%
Free-cash-flow margin−58.2%−35.9%−19.8%−19.1%−7.0%5.2%9.3%
Return on equity——−115.5%−17.3%−19.1%−12.0%−13.3%
Return on assets—−20.6%−13.7%−12.7%−14.2%−9.8%−7.4%
Asset turnover—0.450.440.440.600.800.69
Current ratio—9.4310.405.823.773.982.09
Debt to equity——7.2%25.4%0.0%0.0%92.9%
Interest cover (operating income ÷ interest)n/mn/mn/mn/mn/mn/mn/m
R&D as % of revenue44.5%35.9%32.1%33.9%32.0%28.8%26.7%
Capital spending as % of revenue5.0%1.9%0.7%0.5%0.4%0.4%0.3%

Returns use average equity or assets over the year. Return on equity is left blank when equity is negative or so small that the ratio says nothing (above ±200%); interest cover is left blank above 200 times. Price-based ratios such as P/E are on the valuation page.

Financial health

1 of 2 checks passed · September 30, 2026
What it owns · $835m
Short-term assets $186mLonger-term assets $649m
What it owes, and who funded it · $835m
Short-term liabilities $91mLonger-term liabilities $384mShareholders' equity $360m
  • Short-term assets cover short-term liabilities $186m of assets due within a year against $91m of liabilities due within a year.
  • Short-term assets cover long-term liabilities $186m short-term assets against $384m of longer-dated liabilities.
  • More cash than debt Cash or debt not separately reported. Not assessable.
  • Debt below 40% of shareholders' equity Equity or debt not reported. Not assessable.
  • Debt burden no higher than five years ago Five-year comparison not available. Not assessable.
  • A year's operating cash flow covers at least 20% of debt Cash flow or debt not reported. Not assessable.
  • Operating profit covers interest at least five times over Interest not separately reported. Not assessable.

From Alkami Technology, Inc.'s latest balance sheet as filed. Checks are fixed, documented rules (methodology), counted only where the company reports the figures — a dot means the filing doesn't break the item out. Descriptions of reported data, not advice.

Moat

30 /100

Weak moat

How hard Alkami Technology's competitive advantage looks for rivals to wear away, judged from 6 years of its own filings: returns on capital, pricing power, profit durability, cash conversion and discipline.

  • Returns on capital 4 / 20

    Cash operating profit has been a median 4.9% of total assets over 5 years.

  • Pricing power 18 / 20

    Gross margin has been a median 54.7%, moving by 2.3 percentage points (standard deviation) across 6 years.

  • Durability 10 / 20

    Operating margin has been a median -26.1%; its worst year was -31.3%.

  • Cash conversion 3 / 20

    Free cash flow was positive in 2 of 6 years, at a median -13.1% of revenue.

AI disruption exposure: High. In this industry, the core product is information work that AI systems increasingly perform. The score above includes a 15-point deduction for that exposure (45 before it).

A rules-based reading of reported figures, not a forecast and not investment advice. How the score is built: methodology.

Compare with peers

Head to head: ALKT vs YEXTALKT vs AVPTADEA vs ALKT

More: Application Software stocks compared, Technology sector, rankings of US companies

Figures from Alkami Technology, Inc.'s SEC filings (10-K and 10-Q), retrieved November 1, 2026. How we read and check them: methodology and data sources. Not investment advice. Back to Alkami Technology, Inc.